|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
* Robinhood should be investigated. According to SEC documents there has been up to $180 million in order flow selling (frontrunning) fees for Robinhood in Q2, a doubling from Q1. (Almost two-thirds is options related). Can it double again from ther...
We may be seeing the beginning of a change in market leadership.
While there will be bumps, thuds and even some damage, 2020 will by no means bring about an end to dividend investing.
While some 'pruning' can be necessary, Thursday was a strange day to get clipped.
I think we know, just based on the behavior of this Federal Reserve, that all things being equal a more normalized balance sheet is preferable.
Almost 200 companies are slated to report quarterly results, including 43 S&P 500 constituents.
The planned acquisition of The Medicines Company by Novartis spurs prospects of other deals in the drug business.
Robinhood is bringing a whole new generation of traders into the fold.
Unlike most others, I saw AMTD's huge drop as a buying opportunity, and now look at how it turned out.
* A broad-based gain today * There is a narrative for every Deal and every Bull Market -- but it always changes and sometimes it's faux (e.g. Schwab/TD Ameritrade) The steady and relentless market advance of the last seven weeks continued today. We ...
We're seeing lots of companies snapping up their peers, and the market is applauding.
Buying stocks of Charles Schwab and TD Ameritrade worked out well, after the surge on Nov. 21 when it was announced that Schwab is in serious negotiations to buy AMTD.
With the potential TD Ameritrade deal, clearly E*Trade will not be 'talking to Chuck.'
I would not trade either Schwab or Ameritrade on the long side for fear of a possible antitrust issue.
The brokerage already may have seen its shares discount the recent news about zero-commission trading.
The Trump and Xi administrations are at least looking at the same page. That's more than nothing.
Commissions do cut into the customer's profits, so now with that removed we may see trading come alive even more with options.
When you're the most bummed out about how much you've lost, so is everybody else, and that's when they're willing to part with even the best stocks at really low prices.
As these three big discount brokers move to commission-free trading on certain products, how will they make a profit? And are they now a buy?
TD Ameritrade is poised to offer big returns at a low entry point.
Are things that bad? I remain a non-believer in the recession thesis.